Impact of the new central ethics committee submission process in Quebec

There are multiple academic and non-academic institutions in the province of Quebec that participate in clinical research trials. In the past, each had their own ethics committee. Since all had their own review group and demands, this was creating substantial delays in study start-up and contributed to the decrease number of trials being conducted in the province. Since February 2015, the Quebec Health Ministry has put in place a “central” review system between the institutions. The objective of this project will be to assess if the newly proposed central review process has a positive impact on review timelines and client satisfaction. For the organization, we are always looking for ways to reduce the timelines and improve the processes. The analysis of this new process could have major implications in the site selection process and the allocated resources.

Faculty Supervisor:

Céline Fiset

Student:

Partner:

Bristol-Myers Squibb Canada

Discipline:

Life Sciences

Sector:

Manufacturing; Professional, scientific and technical services

University:

Université de Montréal

Program: